论文部分内容阅读
胺碘酮(ａｍｉｏｄａｒｏｎｅ)是用于治疗室性心律不齐、阵发性室上性心动过速、心房纤颤和心房扑动的有效药物。后来进一步应用于心肌梗死后的治疗以便减少复合心室异位性心律和与之有关并发症的死亡率。胺碘酮提高心肌梗死和心力衰竭病人存活率的疗效还未得到肯定。我们报道1
Amiodarone is an effective drug for the treatment of ventricular arrhythmia, paroxysmal supraventricular tachycardia, atrial fibrillation and atrial flutter. It was later further applied to post-MI treatment to reduce the composite ventricular arrhythmia and associated complications. The efficacy of amiodarone in increasing the survival rate of patients with myocardial infarction and heart failure has not yet been confirmed. We report 1